EOS Imaging : FDA approval for the hipEOS 3.0 software
>510 (k) for new surgical planning software hipEOS3.0 - Yesterday evening, EOS Imaging announced that it had received 510 (k) FDA approval to market hipEOS 3.0, its new surgical planning software for arthroplasty. This new solution belongs to EOSapps, the online 3D surgical planning platform (SpineEOS, hipEOS and KneeEOS). This allows surgeons to check and monitor post-operative results and identify more efficiently patients who are at risk. All in all, the platf...EOS Imaging SA. EOS Imaging SA is a France-based company that manufactures and sells orthopedic imaging systems for orthopedic surgeons, radiologists, and rheumatologists for the diagnosis, surgical planning and follow-up of spine, hip and knee diseases. The EOS orthopedic imaging machine captures images of patients in a standing position with less radiation than a standard X-ray. It also provides three-dimensional images and true size images for surgical planning and monitoring of pathologies. EOS Imaging SA has obtained marketing authorizations in 30 countries including the United States, Canada, Australia and Hong Kong, among others. The Company operates through subsidiaries, including EOS Imaging SA, EOS Imaging Inc, EOS Imaging Canada, EOS Imaging GmbH and Onefit Medical, among others.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.